Panaxium Overview

  • Founded
  • 2016

  • Status
  • Private

  • Employees
  • 17

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.14M

  • Investors
  • 1

Panaxium General Information


Developer of bioelectronic devices designed to heal an injured or diseased human brain. The company's devices create a seamless interface between a neural implant and the brain itself that improves plasticity, direct precision healing and resynchronization of network dysfunctions, enabling physicians to offer a wide range of solutions for neurological ailments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 67 CRS Mirabeau
  • 13100 Aix-en-Provence
  • France
+33 04 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Panaxium Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 07-Dec-2016 $1.14M 00.000 00.000 Completed Startup
1. Accelerator/Incubator 01-Jan-2016 Completed Startup
To view Panaxium’s complete valuation and funding history, request access »

Panaxium Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Panaxium’s complete cap table history, request access »

Panaxium Patents

Panaxium Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3873591-A1 Implantable apparatus for interacting with biological tissue Pending 02-Nov-2018 0000000000
US-20210393950-A1 Implantable apparatus for interacting with biological tissue Pending 02-Nov-2018 0000000000

Panaxium Executive Team (3)

Name Title Board Seat Contact Info
Bradley Schmidt Ph.D Co-Founder & Chief Executive Officer
Jonathan Balfour Executive
Pierre Leleux Scientific Manager
To view Panaxium’s complete executive team members history, request access »

Panaxium Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Panaxium Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Incubateur Impulse Accelerator/Incubator Minority 000 0000 000000 0
To view Panaxium’s complete investors history, request access »